Evaluation of therapeutic effect of compound Danshen dripping pills in the treatment of stable exertional angina pectoris.

Trial Profile

Evaluation of therapeutic effect of compound Danshen dripping pills in the treatment of stable exertional angina pectoris.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2017

At a glance

  • Drugs T 89 (Primary) ; Aspirin
  • Indications Angina pectoris
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Sep 2017 Planned number of patients changed from 60 to 120.
    • 23 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
    • 12 Aug 2017 Planned number of patients changed from 120 to 60.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top